Journal of Hypertension

Journal Abbreviation: J HYPERTENS
ISSN: 0263-6352
eISSN: 1473-5598
Publisher: Lippincott, Williams & Wilkins

Publications (95)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study (2024) Cífková R, Harazny J, Bruthans J, Wohlfahrt P, Krajčoviechová AH, Lánská V, Gelžinský J, et al. Journal article Increased blood pressure after nonsevere COVID-19 (2023) Schmidt-Lauber C, Alba Schmidt E, Hänzelmann S, Petersen EL, Behrendt CA, Twerenbold R, Blankenberg S, et al. Journal article Cardiovascular and health cost impacts of cuff blood pressure underestimation and overestimation of invasive aortic systolic blood pressure (2023) Fonseca R, Palmer AJ, Picone DS, Cox IA, Schultz MG, Black JA, Bos WJ, et al. Journal article Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes (2023) Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder R, Anker SD, Filippatos G, et al. Journal article LONG-TERM REDUCTION IN MORNING AND NIGHTTIME BLOOD PRESSURE AFTER RENAL DENERVATION: 36-MONTH RESULTS FROM SPYRAL HTN-ON MED PILOT TRIAL (2023) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Conference contribution BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCE (2023) Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R, Kannenkeril D Conference contribution RENAL IMAGING IN HYPERTENSION (2023) Schmieder R Conference contribution LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Conference contribution CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Esler M, Cao K, Lobo M, Sharp ASP, Kandzari DE, Mancia G, Bohm M, et al. Conference contribution IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIES (2022) Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder R Conference contribution